These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 23565287)
41. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. Cippitelli A; Bilbao A; Hansson AC; del Arco I; Sommer W; Heilig M; Massi M; Bermúdez-Silva FJ; Navarro M; Ciccocioppo R; de Fonseca FR; Eur J Neurosci; 2005 Apr; 21(8):2243-51. PubMed ID: 15869521 [TBL] [Abstract][Full Text] [Related]
42. Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats. Herling AW; Kilp S; Elvert R; Haschke G; Kramer W Endocrinology; 2008 May; 149(5):2557-66. PubMed ID: 18276749 [TBL] [Abstract][Full Text] [Related]
43. Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats. Lazzari P; Serra V; Marcello S; Pira M; Mastinu A Eur Neuropsychopharmacol; 2017 Jul; 27(7):667-678. PubMed ID: 28377074 [TBL] [Abstract][Full Text] [Related]
44. Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis. Giannone FA; Baldassarre M; Domenicali M; Zaccherini G; Trevisani F; Bernardi M; Caraceni P Lab Invest; 2012 Mar; 92(3):384-95. PubMed ID: 22184091 [TBL] [Abstract][Full Text] [Related]
45. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats. Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537 [TBL] [Abstract][Full Text] [Related]
46. Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats. Gessa GL; Orrù A; Lai P; Maccioni P; Lecca R; Lobina C; Carai MA; Colombo G Psychopharmacology (Berl); 2006 Apr; 185(2):248-54. PubMed ID: 16491428 [TBL] [Abstract][Full Text] [Related]
47. The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats. McLaughlin PJ; Winston KM; Limebeer CL; Parker LA; Makriyannis A; Salamone JD Psychopharmacology (Berl); 2005 Jul; 180(2):286-93. PubMed ID: 15948012 [TBL] [Abstract][Full Text] [Related]
48. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat. Bojanowska E; Radziszewska E J Physiol Pharmacol; 2011 Aug; 62(4):395-402. PubMed ID: 22100840 [TBL] [Abstract][Full Text] [Related]
49. Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice. Cardinal P; Bellocchio L; Clark S; Cannich A; Klugmann M; Lutz B; Marsicano G; Cota D Endocrinology; 2012 Sep; 153(9):4136-43. PubMed ID: 22778221 [TBL] [Abstract][Full Text] [Related]
50. Photoperiodic changes in endocannabinoid levels and energetic responses to altered signalling at CB1 receptors in Siberian hamsters. Ho JM; Smith NS; Adams SA; Bradshaw HB; Demas GE J Neuroendocrinol; 2012 Jul; 24(7):1030-9. PubMed ID: 22420341 [TBL] [Abstract][Full Text] [Related]
51. Cannabinoid-induced tolerance is associated with a CB1 receptor G protein coupling switch that is prevented by ultra-low dose rimonabant. Paquette JJ; Wang HY; Bakshi K; Olmstead MC Behav Pharmacol; 2007 Dec; 18(8):767-76. PubMed ID: 17989514 [TBL] [Abstract][Full Text] [Related]
53. Stimulation of accumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats. Deshmukh RR; Sharma PL Pharmacol Res; 2012 Sep; 66(3):276-82. PubMed ID: 22728691 [TBL] [Abstract][Full Text] [Related]
54. Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant. Martín-García E; Burokas A; Martín M; Berrendero F; Rubí B; Kiesselbach C; Heyne A; Gispert JD; Millán O; Maldonado R J Neurochem; 2010 Mar; 112(5):1338-13351. PubMed ID: 20028452 [TBL] [Abstract][Full Text] [Related]
55. Cannabinoid CB₁ receptor restrains accentuated activity of hypothalamic corticotropin-releasing factor and brainstem tyrosine hydroxylase neurons in endotoxemia-induced hypophagia in rats. Rorato R; Reis WL; de Carvalho Borges B; Antunes-Rodrigues J; Elias LL Neuropharmacology; 2012 Jul; 63(1):154-60. PubMed ID: 22138163 [TBL] [Abstract][Full Text] [Related]
56. mGluR1/5 activation in the lateral hypothalamus increases food intake via the endocannabinoid system. Sánchez-Fuentes A; Marichal-Cancino BA; Méndez-Díaz M; Becerril-Meléndez AL; Ruiz-Contreras AE; Prospéro-Garcia O Neurosci Lett; 2016 Sep; 631():104-108. PubMed ID: 27542344 [TBL] [Abstract][Full Text] [Related]
57. The effect of am 251, a cannabinoid CB1 receptor antagonist, on food intake in rats. Rutkowska M Acta Pol Pharm; 2004; 61(5):401-3. PubMed ID: 15747698 [TBL] [Abstract][Full Text] [Related]
58. Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide. Osei-Hyiaman D; Depetrillo M; Harvey-White J; Bannon AW; Cravatt BF; Kuhar MJ; Mackie K; Palkovits M; Kunos G Neuroendocrinology; 2005; 81(4):273-82. PubMed ID: 16131814 [TBL] [Abstract][Full Text] [Related]
59. Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake. Verty AN; McFarlane JR; McGregor IS; Mallet PE Neuropharmacology; 2004 Sep; 47(4):593-603. PubMed ID: 15380376 [TBL] [Abstract][Full Text] [Related]
60. Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. Avraham Y; Menachem AB; Okun A; Zlotarav O; Abel N; Mechoulam R; Berry EM Brain Res Bull; 2005 Mar; 65(2):117-23. PubMed ID: 15763177 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]